Hypertension
Conditions
Keywords
laser Acupuncture Treatment, Blood Pressure, Hypertension Haemodialysis Patients
Brief summary
The purpose of this study is to find the effect of acupuncture laser therapy on Blood Pressure in Hypertension Haemodialysis Patients
Detailed description
In patients with end-stage renal disease (ESRD) receiving dialysis, elevated blood pressure is common and poorly controlled in general. Although volume overload and sodium retention appear to be the main pathogenic mechanism of hypertension in this population, other factors such as increased arterial stiffness, activation of renin-angiotensin-aldosterone system, sleep apnea, activation of sympathetic nervous system, and use of recombinant erythropoietin may be also involved. Acupuncture laser therapy, which uses low-level laser treatment at specific acupuncture points, has shown promise in reducing blood pressure without invasive procedures. However, its specific efficacy in hemodialysis patients remains underexplored, necessitating this research
Interventions
Application of low-level laser therapy to patients with chronic kidney disease to evaluate its effects on pain, circulation, and functional outcomes
Sponsors
Sinai University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Masking description
This is an open-label study. Both the participants and investigators are aware of the intervention (low-level laser therapy)
Intervention model description
This expected prospective randomized control trial study will involve 60 haemodialysis patients with hypertension. The patients in the experimental group (E) will subject, medical treatment besides acupuncture laser therapy. Medical treatment will be used in the control group (C). Sleep quality and Blood pressure measurement will be used in the assessment of outcome
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* sixty hemodialysis patients undergoing physical therapy treatments will participate in the study. Their mean age will range from (18-65) years old
Exclusion criteria
* a failure to take part in more than three light therapy sessions; a kidney transplant; and death
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in systolic and diastolic blood pressure | Baseline and after 4 weeks of low-level laser therapy | Blood pressure will be measured using a calibrated sphygmomanometer |
| Blood pressure | Baseline and after 4 weeks of low-level laser therapy | Blood pressure will be measured using a calibrated sphygmomanometer |
Countries
Egypt
Contacts
CONTACTShimaa Galal Elsayed, lecturer
Outcome results
None listed